In people with type 2 diabetes, GLP-1 receptor agonists are linked to a higher chance of gout flare-ups, probably because rapid weight loss releases stored uric acid into the bloodstream, requiring...
Evidence from Studies
No evidence studies found yet.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.